Skip to main content
. 2000 Jun;68(6):3635–3641. doi: 10.1128/iai.68.6.3635-3641.2000

TABLE 2.

Comparison of C. trachomatis and C. pneumoniae infection of BSMC

Treatmenta No. of inclusionsb IL-6 secreted (pg/ml)c
Mock 150 (40)
C. trachomatis D/IC Cal 8 4,096 (1,006)d 697 (187)e
C. pneumoniae TW-183 17,241 (3,138) 6,217 (385)
a

BSMC monolayers grown in 11-mm-diameter culture tubes were infected with 106 IFU of C. trachomatis D/IC Cal 8 or C. pneumoniae TW-183. Mock-infected cells were inoculated with a suspension of lysed BGM cells. 

b

Inclusions per coverslip were counted after immunofluorescence staining at 72 h after infection. Values are means (with standard deviations) of three experiments. 

c

IL-6 concentrations in culture supernatants were determined by ELISA at 48 h after infection. Results are means (with standard deviations) of three experiments. 

d

Significantly different from values for C. pneumoniae-infected cells (Welch t test, P ≤ 0.03). 

e

Significantly different from values for C. pneumoniae-infected cells (Welch t test, P ≤ 0.001) and mock-infected cells (Welch t test, P ≤ 0.04).